Immune and Genomic Markers in ALK+ NSCLC

Clinical trial NCT04881916 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04881916
Sponsor: Massachusetts General Hospital
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Anaplastic Lymphoma Kinase Gene Translocation Non-Small Cell Lung Cancer

Start date: 2021-12-01
Primary completion: 2027-07-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.